US Stem Cell Inc (USRM)

[andyshow]

http://investorstemcell.com/investing/biohearts-steadfast-commitment/

Today, Bioheart is a combination of distinct business enterprises. We estimate that the products and services we offer through US Stem Cell Training, Vetbiologics, and US Stem Cell Clinics has the potential, although we cannot provide assurances as to if and when it will be accomplished, to drive up to $100 million dollars in cumulative peak annual revenues. What we are establishing is a foundation of value in the products and services we are and plan to sell from US Stem Cell Training, Vetbiologics, and US Stem Cell clinics. Through our third quarter, as reported, we have increased year to date revenues from $56 thousand in 2013 to $1.6 million in 2014. Our strategy is to expand the revenues generated from each of these subsidiaries and to reinvest the profits we generate into our Bioheart clinical development pipeline. - See more at: http://investorstemcell.com/investing/biohearts-steadfast-commitment/#sthash.Ff6jbhap.dpuf